Amplifon S.p.A. stock (IT0004056880): Hearing aid leader navigates global expansion

Amplifon S.p.A. operates as a global leader in hearing care services, offering diagnostics, hearing aids, and related accessories through a network spanning multiple continents. The company, listed on the Milan Stock Exchange, reported steady growth in its latest financials, with revenue reaching €2.3 billion for the full year 2025 as published in its annual report as of March 2026. This performance underscores its resilience in a competitive sector.

As of: 13.05.2026

By the editorial team – specialized in equity coverage.

Amplifon S.p.A.: core business model

Amplifon S.p.A. specializes in comprehensive hearing care, providing personalized solutions from initial assessments to advanced hearing aid fittings. Founded in 1950, the company has built a franchise-based model combined with direct ownership, operating over 5,000 points of sale in 26 countries as of its 2025 annual report. This hybrid approach allows scalability while maintaining local expertise.

The business revolves around three pillars: retail services, wholesale distribution of hearing devices, and digital health innovations. Retail remains the core, generating the majority of revenue through consultations and product sales. Amplifon partners with leading manufacturers like Phonak and Widex to offer premium devices tailored to individual needs.

For US investors, Amplifon's presence in North America via its Miracle-Ear brand provides direct exposure to the $7 billion US hearing aid market, which is seeing increased demand due to demographic shifts, according to sector data from Statista as of 2025.

Main revenue and product drivers for Amplifon S.p.A.

Retail services account for approximately 90% of Amplifon's revenue, driven by an aging global population and rising awareness of hearing health. In 2025, the company served over 2 million clients, with like-for-like revenue growth of 8.2% reported in its full-year results published March 2026. Key products include behind-the-ear and receiver-in-canal hearing aids, supplemented by accessories like rechargeable batteries and wireless streamers.

Geographic diversification is a major driver, with Europe contributing 70% of sales, followed by the Americas at 20% and Asia-Pacific at 10%. The US market, accessed through Miracle-Ear clinics, benefits from favorable reimbursement trends under Medicare expansions for hearing coverage starting 2023.

Digital tools, such as the Amplifon app for remote adjustments, are gaining traction, supporting a shift toward tele-audiology that enhances client retention and opens recurring revenue streams.

Industry trends and competitive position

The global hearing aid market is projected to grow at 6.5% CAGR through 2030, fueled by prevalence of hearing loss affecting 1.5 billion people worldwide per WHO estimates. Amplifon competes with players like Sonova and Demant, differentiating through its service-oriented model rather than pure manufacturing.

Amplifon's franchise network provides cost advantages and rapid market penetration, positioning it well against OTC hearing aid entrants in the US following FDA deregulation in 2022. Its EBITDA margin of 15.2% in 2025 reflects operational efficiency amid industry consolidation.

Why Amplifon S.p.A. matters for US investors

US investors gain exposure to Europe's leading hearing care provider via Amplifon's ADR availability and Milan listing, tapping into a defensive healthcare sector with stable demand. The company's 150+ US clinics under Miracle-Ear directly serve the lucrative American market, where 30 million adults report hearing difficulties.

With currency hedging and diversified revenue, Amplifon offers a hedge against US economic volatility while benefiting from global aging trends relevant to US demographics.

Conclusion

Amplifon S.p.A. maintains a strong position in the hearing care industry through its extensive retail network and focus on client-centric services. Recent financials highlight consistent growth, while expansion in key markets like the US supports long-term potential. Investors monitor upcoming quarterly updates for sustained performance amid evolving regulations and technological advances.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.